331 related articles for article (PubMed ID: 19029171)
1. Prognostic implications of hypoglycaemic episodes during hospitalisation for myocardial infarction in patients with type 2 diabetes: a report from the DIGAMI 2 trial.
Mellbin LG; Malmberg K; Waldenström A; Wedel H; Rydén L;
Heart; 2009 May; 95(9):721-7. PubMed ID: 19029171
[TBL] [Abstract][Full Text] [Related]
2. Intense metabolic control by means of insulin in patients with diabetes mellitus and acute myocardial infarction (DIGAMI 2): effects on mortality and morbidity.
Malmberg K; Rydén L; Wedel H; Birkeland K; Bootsma A; Dickstein K; Efendic S; Fisher M; Hamsten A; Herlitz J; Hildebrandt P; MacLeod K; Laakso M; Torp-Pedersen C; Waldenström A;
Eur Heart J; 2005 Apr; 26(7):650-61. PubMed ID: 15728645
[TBL] [Abstract][Full Text] [Related]
3. Intensified insulin-based glycaemic control after myocardial infarction: mortality during 20 year follow-up of the randomised Diabetes Mellitus Insulin Glucose Infusion in Acute Myocardial Infarction (DIGAMI 1) trial.
Ritsinger V; Malmberg K; Mårtensson A; Rydén L; Wedel H; Norhammar A
Lancet Diabetes Endocrinol; 2014 Aug; 2(8):627-33. PubMed ID: 24831989
[TBL] [Abstract][Full Text] [Related]
4. The impact of glucose lowering treatment on long-term prognosis in patients with type 2 diabetes and myocardial infarction: a report from the DIGAMI 2 trial.
Mellbin LG; Malmberg K; Norhammar A; Wedel H; Rydén L;
Eur Heart J; 2008 Jan; 29(2):166-76. PubMed ID: 18156614
[TBL] [Abstract][Full Text] [Related]
5. The relationship between glycaemic variability and cardiovascular complications in patients with acute myocardial infarction and type 2 diabetes: a report from the DIGAMI 2 trial.
Mellbin LG; Malmberg K; Rydén L; Wedel H; Vestberg D; Lind M
Eur Heart J; 2013 Feb; 34(5):374-9. PubMed ID: 23144046
[TBL] [Abstract][Full Text] [Related]
6. Effect of gender on prognosis in patients with myocardial infarction and type 2 diabetes.
Venskutonyte L; Malmberg K; Norhammar A; Wedel H; Rydén L
J Intern Med; 2010 Jul; 268(1):75-82. PubMed ID: 20210844
[TBL] [Abstract][Full Text] [Related]
7. Prognostic implications of glucose-lowering treatment in patients with acute myocardial infarction and diabetes: experiences from an extended follow-up of the Diabetes Mellitus Insulin-Glucose Infusion in Acute Myocardial Infarction (DIGAMI) 2 Study.
Mellbin LG; Malmberg K; Norhammar A; Wedel H; Rydén L;
Diabetologia; 2011 Jun; 54(6):1308-17. PubMed ID: 21359582
[TBL] [Abstract][Full Text] [Related]
8. [Metabolic control by means of insulin in patients with type 2 diabetes and acute myocardial infarction (DIGAMI 2): effects on mortality and morbidity--secondary publication].
Gustafsson I; Malmberg K; Rydén L; Wedel H; Birkeland K; Bootsma A; Dickstein K; Efendic S; Fisher M; Hamsten A; Herlitz J; Hildebrandt PR; MacLeod K; Laakso M; Torp-Pedersen CT; Waldenström A;
Ugeskr Laeger; 2006 Feb; 168(6):581-4. PubMed ID: 16476220
[TBL] [Abstract][Full Text] [Related]
9. Association between hyper- and hypoglycaemia and 2 year all-cause mortality risk in diabetic patients with acute coronary events.
Svensson AM; McGuire DK; Abrahamsson P; Dellborg M
Eur Heart J; 2005 Jul; 26(13):1255-61. PubMed ID: 15821004
[TBL] [Abstract][Full Text] [Related]
10. Self-rated health predicts outcome in patients with type 2 diabetes and myocardial infarction: a DIGAMI 2 quality of life sub-study.
Venskutonyte L; Brismar K; Öhrvik J; Rydén L; Kjellström B
Diab Vasc Dis Res; 2013 Jul; 10(4):361-7. PubMed ID: 23673377
[TBL] [Abstract][Full Text] [Related]
11. Relationship of glycaemic control and hypoglycaemic episodes to 4-year cardiovascular outcomes in people with type 2 diabetes starting insulin.
Freemantle N; Danchin N; Calvi-Gries F; Vincent M; Home PD
Diabetes Obes Metab; 2016 Feb; 18(2):152-8. PubMed ID: 26511332
[TBL] [Abstract][Full Text] [Related]
12. Inverse relation of body weight and weight change with mortality and morbidity in patients with type 2 diabetes and cardiovascular co-morbidity: an analysis of the PROactive study population.
Doehner W; Erdmann E; Cairns R; Clark AL; Dormandy JA; Ferrannini E; Anker SD
Int J Cardiol; 2012 Dec; 162(1):20-6. PubMed ID: 22037349
[TBL] [Abstract][Full Text] [Related]
13. Does glucose level at hospital discharge predict one-year mortality in patients with diabetes mellitus treated with percutaneous coronary intervention for ST-segment elevation myocardial infarction?
Gasior M; Pres D; Stasik-Pres G; Lech P; Gierlotka M; Lekston A; Hawranek M; Tajstra M; Kalarus Z; Poloński L
Kardiol Pol; 2008 Jan; 66(1):1-8; discussion 9-11. PubMed ID: 18266182
[TBL] [Abstract][Full Text] [Related]
14. Influence of an antidiabetic treatment with sulfonylurea drugs on long-term survival after acute myocardial infarction in patients with type 2 diabetes. The LAngendreer Myocardial infarction and Blood glucose in Diabetic patients Assessment (LAMBDA).
Meier JJ; Deifuss S; Klamann A; Schmiegel W; Nauck MA;
Exp Clin Endocrinol Diabetes; 2003 Sep; 111(6):344-50. PubMed ID: 14520601
[TBL] [Abstract][Full Text] [Related]
15. Effects of fasting blood glucose, diabetes treatment, blood pressure and anti-hypertension treatment on cardiovascular disease incidence: a 30-year follow-up study of 740 incident patients with Type 2 diabetes.
Jansson SP; Andersson DK; Svärdsudd K
Diabet Med; 2013 Mar; 30(3):349-57. PubMed ID: 23278364
[TBL] [Abstract][Full Text] [Related]
16. Relationship between spontaneous and iatrogenic hypoglycemia and mortality in patients hospitalized with acute myocardial infarction.
Kosiborod M; Inzucchi SE; Goyal A; Krumholz HM; Masoudi FA; Xiao L; Spertus JA
JAMA; 2009 Apr; 301(15):1556-64. PubMed ID: 19366775
[TBL] [Abstract][Full Text] [Related]
17. Glucose-lowering therapy after myocardial infarction: more questions than answers.
Radke PW; Schunkert H
Eur Heart J; 2008 Jan; 29(2):141-3. PubMed ID: 18199566
[TBL] [Abstract][Full Text] [Related]
18. Frequency and predictors of hypoglycaemia in Type 1 and insulin-treated Type 2 diabetes: a population-based study.
Donnelly LA; Morris AD; Frier BM; Ellis JD; Donnan PT; Durrant R; Band MM; Reekie G; Leese GP;
Diabet Med; 2005 Jun; 22(6):749-55. PubMed ID: 15910627
[TBL] [Abstract][Full Text] [Related]
19. Does hypoglycaemia increase the risk of cardiovascular events? A report from the ORIGIN trial.
; Mellbin LG; Rydén L; Riddle MC; Probstfield J; Rosenstock J; Díaz R; Yusuf S; Gerstein HC
Eur Heart J; 2013 Oct; 34(40):3137-44. PubMed ID: 23999452
[TBL] [Abstract][Full Text] [Related]
20. The association between hyperglycaemia on admission and 180-day mortality in acute myocardial infarction patients with and without diabetes.
Ainla T; Baburin A; Teesalu R; Rahu M
Diabet Med; 2005 Oct; 22(10):1321-5. PubMed ID: 16176190
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
